Imidazole → 2-(1H-Imidazol-1-yl)pyridine-4-carboxylic acid
Reaktionsgleichung
Br[C:2]1[CH:3]=[C:4]([CH:8]=[CH:9][N:10]=1)[C:5]([OH:7])=[O:6].[NH:11]1[CH:15]=[CH:14][N:13]=[CH:12]1.C([O-])([O-])=O.[Cs+].[Cs+]>CS(C)=O.[Cu]I>[N:11]1([C:2]2[CH:3]=[C:4]([CH:8]=[CH:9][N:10]=2)[C:5]([OH:7])=[O:6])[CH:15]=[CH:14][N:13]=[CH:12]1Komponenten
6
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Reaktionsbedingungen
- Temperatur
- 125 °C
Versuchsvorschrift
To a solution of 2-bromoisonicotinic acid (1.87 g, 9.26 mmol), 1H-imidazole (573 mg, 8.42 mmol) and Cs2CO3 (6.03 g, 18.5 mmol) in DMSO (18.6 mL), was added CuI (176 mg, 0.926 mmol). The mixture was heated to 125° C., stirred for 18 hours, cooled to room temperature, filtered and purified by preparative HPLC (10-90% acetonitrile in water) to give the title compound as a light pink solid (1.72 g, 98%). MS 190 (MH+).
Aufarbeitung
- temperaturecooled to room temperature
- filtrationfiltered
- custompurified by preparative HPLC (10-90% acetonitrile in water)
Quellen und Nachweise
- ORD-Eintrag
- ord-195a383528bd4598aa4ea54753f219f8
- Quelldatensatz
- uspto-grants-2016_08
- Patentnummer
- US09420814B2
Notizen zur Reaktion
Wird geladen…